Compounds found that alter cell signaling, could lead to new breast cancer treatments
Tuesday, March 26, 2013 - 08:30
in Health & Medicine
Using a broad spectrum of analytical tools, scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a class of novel compounds that can alter cell signaling activity, resulting in a variety of responses including a strong anti-inflammatory effect. These findings could lead to new strategies for treating diseases such as breast cancer.